Pharma advertising measurement has been stuck in the past. But it doesn’t have to be.  For years, pharma marketers have been stuck chasing the wrong numbers. Impressions. Clicks. Bounce rates. The list goes on. These vanity metrics might look good on a dashboard, but they don’t tell you if your campaign actually moved the needle….

Where are the best digital spaces to find healthcare professionals (HCPs) in 2025? If you picture doctors, nurses and other HCPs buried in online medical journals, or engaging in discussions on specialized platforms like Doximity, you’re probably not wrong… But that’s only part of the story. The thing is that HCPs are just like the…

Nurse Practitioners (NPs) and Physician Assistants (PAs) are no longer just “support” staff for physicians. These clinicians are now taking on much bigger roles in patient care, including the ability to prescribe medications without physician oversight.  The COVID-19 pandemic accelerated the already growing trend of expanding NPs’ and PAs’ scope of practice. Now, five years…

The digital advertising landscape is shifting rapidly, and for healthcare and pharmaceutical marketers, the stakes are higher than ever. With evolving privacy regulations, increasing scrutiny on data practices and the challenge of balancing precision targeting with consumer protection, advertisers must rethink their strategies to stay effective and compliant. To tackle these pressing issues, PurpleLab recently…

A healthcare media agency wanted to increase awareness of their brand with additional direct to consumer (DTC), HIPAA and NAI compliant, privacy safe audiences. They wanted to drive prescriptions for consumers with migraines. The audiences needed to be applicable across channels and activatable on their preferred demand side platform (DSP).

Authored by Lauren Kushner, Head of Healthcare at MiQ, and Ted Sweetser, VP of Advertising Partnerships and Strategy at PurpleLab. 2024 was a year of considerable change for the pharmaceutical industry. The biggest trend was undoubtedly the progression of the Inflation Reduction Act’s negotiated drug pricing, which sees CMS negotiating on pricing for a published…

Healthcare advertisers and their marketing partners face challenges that other direct to consumer advertisers may not necessarily be confronted with. Namely, the ever-evolving world of privacy regulation and the requirements enacted by the federal and state governments with the goal of helping preserve patient anonymity.

Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge. In a new webinar, sponsored by PurpleLab, experts explore how PurpleLab’s data solutions can help foster a deeper understanding of physician prescribing behavior.

As the pharmaceutical and healthcare media industries face unprecedented change, the Preparing for 2025 roundtable convened leading experts to chart a path forward. Against a backdrop of rising patient expectations, accelerating technological advancements, and increasing regulatory pressures, this collaborative forum sought to address critical challenges while uncovering collective alignment for sustainable success.